Canopus BioPharma is trading at 1.0E-4 as of the 13th of January 2025, a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Canopus BioPharma has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 24th of January 2023 and ending today, the 13th of January 2025. Click here to learn more.
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. Canopus BioPharma Incorporated is based in Santa Monica, California. The company has 9.3 M outstanding shares. More on Canopus BioPharma Incorporated
Canopus BioPharma Incorporated [CBIA] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 364.56 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Canopus BioPharma's market, we take the total number of its shares issued and multiply it by Canopus BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Canopus BioPharma conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 9.3 M outstanding shares.
Canopus BioPharma generates positive cash flow from operations, but has no cash available
Check Canopus BioPharma Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Canopus BioPharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Money Flow Index Now
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Other Information on Investing in Canopus Pink Sheet
Canopus BioPharma financial ratios help investors to determine whether Canopus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Canopus with respect to the benefits of owning Canopus BioPharma security.